Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murielle Mauer

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2023
EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet needMaike Collienne, Anouk Neven, Carmela Caballero, et al.
The Lancet. Oncology|October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Annals of Surgery|February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
The Lancet. Oncology|September 15, 2022
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trialMary O'Brien, Luis Paz-Ares, Sandrine Marreaud, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2019
Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programCarmela Caballero, Susen Burock, Lucia Carrion-Alvarez, et al.
The Journal of Pathology. Clinical Research|September 4, 2021
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastasesPieter Mh Nierop, Diederik J Höppener, Florian E Buisman, et al.
JAMA Surgery|September 17, 2025
Diagnostic Accuracy of Imaging in Assessing Nonviability of Disappearing Colorectal Liver MetastasisKozo Kataoka, Murielle Mauer, Manabu Shiozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2022
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) surveySara Pilotto, Alice Avancini, Jessica Menis, et al.
JAMA Network Open|August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-AnalysisUlrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 4, 2023
EORTC 1409 GITCG/ESSO 01 - A prospective colorectal liver metastasis database for borderline or initially unresectable diseases (CLIMB): Lessons learnt from real life. From paradigm to unmet needMaike Collienne, Anouk Neven, Carmela Caballero, et al.
The Lancet. Oncology|October 15, 2013
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trialBernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, et al.
Annals of Surgery|February 9, 2012
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)Halfdan Sorbye, Murielle Mauer, Thomas Gruenberger, et al.
The Lancet. Oncology|September 15, 2022
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trialMary O'Brien, Luis Paz-Ares, Sandrine Marreaud, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2019
Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programCarmela Caballero, Susen Burock, Lucia Carrion-Alvarez, et al.
The Journal of Pathology. Clinical Research|September 4, 2021
Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastasesPieter Mh Nierop, Diederik J Höppener, Florian E Buisman, et al.
JAMA Surgery|September 17, 2025
Diagnostic Accuracy of Imaging in Assessing Nonviability of Disappearing Colorectal Liver MetastasisKozo Kataoka, Murielle Mauer, Manabu Shiozawa, et al.
Lung Cancer (Amsterdam, Netherlands)|June 12, 2022
Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) surveySara Pilotto, Alice Avancini, Jessica Menis, et al.
JAMA Network Open|August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-AnalysisUlrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
Cancer Treatment Reviews|April 3, 2025
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastasesGiacomo Bregni, Richard Adams, Reto Bale, et al.
Pageof 3